Brett Dabruzzo, PharmD

Director, Medical Affairs
AbbVie, Madison, NJ, USA

Poster(s):

• (10) Economic impact of early vs. late initiation of atogepant for the preventive treatment of migraine
  Wednesday, October 29, 2025